BRPI0409566A - compostos de ácido fosfÈnico como inibidores de serina protease - Google Patents
compostos de ácido fosfÈnico como inibidores de serina proteaseInfo
- Publication number
- BRPI0409566A BRPI0409566A BRPI0409566-9A BRPI0409566A BRPI0409566A BR PI0409566 A BRPI0409566 A BR PI0409566A BR PI0409566 A BRPI0409566 A BR PI0409566A BR PI0409566 A BRPI0409566 A BR PI0409566A
- Authority
- BR
- Brazil
- Prior art keywords
- serine protease
- phosphonic acid
- acid compounds
- protease inhibitors
- inhibitors
- Prior art date
Links
- 150000003009 phosphonic acids Chemical class 0.000 title abstract 3
- 239000003001 serine protease inhibitor Substances 0.000 title abstract 3
- 102000012479 Serine Proteases Human genes 0.000 abstract 1
- 108010022999 Serine Proteases Proteins 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3882—Arylalkanephosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
"COMPOSTOS DE áCIDO FOSFÈNICO COMO INIBIDORES DE SERINA PROTEASE". A presente invenção refere-se a compostos de ácido fosfónico úteis como inibidores de serina protease, suas composições e métodos para tratamento de distúrbios inflamatórios e mediados por serina protease.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/414,782 US7459461B2 (en) | 2001-10-19 | 2003-04-16 | Phosphonic acid compounds as inhibitors of serine proteases |
PCT/US2004/011490 WO2004094441A2 (en) | 2003-04-16 | 2004-04-14 | Piperazine containing phosphonic acid compounds as inhibitors of serine proteases |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0409566A true BRPI0409566A (pt) | 2006-04-18 |
Family
ID=33309497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0409566-9A BRPI0409566A (pt) | 2003-04-16 | 2004-04-14 | compostos de ácido fosfÈnico como inibidores de serina protease |
Country Status (21)
Country | Link |
---|---|
US (17) | US7459461B2 (pt) |
EP (1) | EP1620446B1 (pt) |
JP (1) | JP4526534B2 (pt) |
KR (1) | KR101106574B1 (pt) |
CN (1) | CN100475824C (pt) |
AU (1) | AU2004232941B2 (pt) |
BR (1) | BRPI0409566A (pt) |
CA (1) | CA2523203C (pt) |
CR (1) | CR8046A (pt) |
EA (1) | EA200501463A1 (pt) |
EC (1) | ECSP056106A (pt) |
ES (1) | ES2399884T3 (pt) |
HR (1) | HRP20050899A2 (pt) |
ME (1) | MEP48608A (pt) |
MX (1) | MXPA05011218A (pt) |
NO (1) | NO20055396L (pt) |
NZ (1) | NZ543139A (pt) |
RS (1) | RS20050778A (pt) |
UA (1) | UA80869C2 (pt) |
WO (1) | WO2004094441A2 (pt) |
ZA (1) | ZA200509249B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7459461B2 (en) | 2001-10-19 | 2008-12-02 | Ortho-Mcneil Pharmaceutical, Inc. | Phosphonic acid compounds as inhibitors of serine proteases |
GB0224084D0 (en) | 2002-10-16 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
GB0308333D0 (en) * | 2003-04-10 | 2003-05-14 | Glaxo Group Ltd | Novel compounds |
US20060293298A1 (en) * | 2003-04-10 | 2006-12-28 | Bamford Mark J | Compounds |
KR101326537B1 (ko) * | 2006-11-30 | 2013-11-08 | (주)아모레퍼시픽 | 카텝신 g 발현 억제제 조성물 |
AU2008306327B2 (en) * | 2007-10-04 | 2014-05-15 | Roche Innovation Center Copenhagen A/S | Micromirs |
EP2058011A1 (en) * | 2007-11-07 | 2009-05-13 | Wittycell | Nkt cell activating gycolipids covalently bound antigens and/or drug |
BR112012015633A2 (pt) | 2009-12-25 | 2018-05-29 | Daiichi Sankyo Company, Limited | "composto com anel de sete membros e seu uso farmacêutico" |
EP3193906B1 (en) * | 2014-09-18 | 2020-11-11 | The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of Holy and Undiv. Trinity of Queen Elizabeth near Dublin | Use of peptide inhibitors of il-36 proteolytic processing for the treatment and/or reduction of inflammation |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE633914A (pt) | 1962-06-22 | |||
US4511551A (en) * | 1982-11-18 | 1985-04-16 | Unique Technologies, Incorporated | Method and composition for the detection of a precancerous or leukemic condition in mammals |
AT380490B (de) * | 1984-09-06 | 1986-05-26 | Voest Alpine Ag | Vorrichtung zur gewinnung der fuehlbaren waerme von schuettfaehigem heissgut |
JPS61151199A (ja) * | 1984-12-26 | 1986-07-09 | Otsuka Pharmaceut Factory Inc | カルボン酸アミド誘導体 |
US4704382A (en) | 1985-07-29 | 1987-11-03 | G. D. Searle & Co. | Phenylpiperazine phosphonates |
US4822780A (en) | 1987-07-08 | 1989-04-18 | Otsuka Pharmaceutical Factory, Inc. | Carboxamide compounds |
US5508273A (en) | 1993-12-30 | 1996-04-16 | Ortho Pharmaceutical Corporation | Substituted phosphonic acids and derivatives useful in treating bone wasting diseases |
AU6458396A (en) | 1995-07-17 | 1997-02-18 | Cephalon, Inc. | Phosphorous-containing cysteine and serine protease inhibitors |
WO1998018794A1 (fr) | 1996-10-25 | 1998-05-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Nouveaux composes d'amide heterocycliques et leur utilisation a des fins medicinales |
CN1160075C (zh) | 1998-03-11 | 2004-08-04 | 卫福有限公司 | 杂环酰胺化合物在制备IgE抗体产生抑制剂中的用途 |
US7459461B2 (en) * | 2001-10-19 | 2008-12-02 | Ortho-Mcneil Pharmaceutical, Inc. | Phosphonic acid compounds as inhibitors of serine proteases |
NZ532372A (en) | 2001-10-19 | 2007-07-27 | Ortho Mcneil Pharm Inc | Phosphonic acid compounds as inhibitors of serine proteases |
US20090143396A1 (en) * | 2005-10-12 | 2009-06-04 | Malecha James W | Sulfonyl-Substituted Aryl Compounds as Modulators of Peroxisome Proliferator Activated Receptors |
-
2003
- 2003-04-16 US US10/414,782 patent/US7459461B2/en not_active Expired - Fee Related
-
2004
- 2004-04-14 KR KR1020057019811A patent/KR101106574B1/ko not_active IP Right Cessation
- 2004-04-14 EA EA200501463A patent/EA200501463A1/ru unknown
- 2004-04-14 UA UAA200509837A patent/UA80869C2/xx unknown
- 2004-04-14 WO PCT/US2004/011490 patent/WO2004094441A2/en active Application Filing
- 2004-04-14 ME MEP-486/08A patent/MEP48608A/xx unknown
- 2004-04-14 RS YUP-2005/0778A patent/RS20050778A/sr unknown
- 2004-04-14 AU AU2004232941A patent/AU2004232941B2/en not_active Ceased
- 2004-04-14 CA CA2523203A patent/CA2523203C/en not_active Expired - Fee Related
- 2004-04-14 ES ES04759852T patent/ES2399884T3/es not_active Expired - Lifetime
- 2004-04-14 JP JP2006510026A patent/JP4526534B2/ja not_active Expired - Fee Related
- 2004-04-14 MX MXPA05011218A patent/MXPA05011218A/es unknown
- 2004-04-14 CN CNB2004800165009A patent/CN100475824C/zh not_active Expired - Fee Related
- 2004-04-14 BR BRPI0409566-9A patent/BRPI0409566A/pt not_active IP Right Cessation
- 2004-04-14 NZ NZ543139A patent/NZ543139A/en unknown
- 2004-04-14 EP EP04759852A patent/EP1620446B1/en not_active Expired - Lifetime
-
2005
- 2005-10-14 HR HR20050899A patent/HRP20050899A2/xx not_active Application Discontinuation
- 2005-10-14 CR CR8046A patent/CR8046A/es not_active Application Discontinuation
- 2005-10-14 EC EC2005006106A patent/ECSP056106A/es unknown
- 2005-11-15 ZA ZA200509249A patent/ZA200509249B/en unknown
- 2005-11-15 NO NO20055396A patent/NO20055396L/no not_active Application Discontinuation
-
2008
- 2008-10-24 US US12/288,993 patent/US20090137528A1/en not_active Abandoned
- 2008-10-24 US US12/288,999 patent/US20090118234A1/en not_active Abandoned
- 2008-10-24 US US12/288,998 patent/US8198440B2/en not_active Expired - Fee Related
- 2008-10-24 US US12/289,000 patent/US20090118504A1/en not_active Abandoned
- 2008-10-24 US US12/290,027 patent/US20090131671A1/en not_active Abandoned
- 2008-10-24 US US12/290,028 patent/US8247599B2/en not_active Expired - Fee Related
- 2008-10-24 US US12/288,920 patent/US8394804B2/en not_active Expired - Fee Related
- 2008-10-24 US US12/288,941 patent/US8178673B2/en not_active Expired - Fee Related
- 2008-10-24 US US12/288,992 patent/US20090124581A1/en not_active Abandoned
-
2010
- 2010-12-20 US US12/972,891 patent/US8212039B2/en not_active Expired - Fee Related
- 2010-12-20 US US12/972,848 patent/US8461195B2/en not_active Expired - Fee Related
- 2010-12-20 US US12/972,744 patent/US8304430B2/en not_active Expired - Fee Related
- 2010-12-20 US US12/973,013 patent/US8207338B2/en not_active Expired - Fee Related
-
2012
- 2012-05-15 US US13/471,876 patent/US8497373B2/en not_active Expired - Fee Related
- 2012-07-17 US US13/550,963 patent/US8609888B2/en not_active Expired - Fee Related
-
2013
- 2013-06-19 US US13/921,476 patent/US8703957B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0413582A (pt) | compostos, composições e métodos para inibir a atividade de proteasome | |
CR7332A (es) | INHIBIDORES DEL FACTOR Xa Y DE OTRAS PROTEASAS DE SERINA IMPLICADAS EN LA CASCADA DE LA COAGULACION | |
ATE456552T1 (de) | Von serinaminosäure abgeleitete prodrugs von propofol, zusammensetzungen, anwendungen und kristalline formen davon | |
BRPI0507052A (pt) | inibidores de quìnase | |
MX339402B (es) | Composiciones y metodos que comprenden variantes de serina proteasa. | |
SE0202241D0 (sv) | Novel Compounds | |
DE602006020875D1 (de) | Oberflächenaktive peroxycarbonsäurezusammensetzungen | |
UA83875C2 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
MX2009008925A (es) | Compuestos de la formula (i) como inhibidores de proteasa de serina. | |
EA200802054A1 (ru) | Ингибиторы фермента | |
CR10766A (es) | Inhibidores de metaloproteasa derivados de heterociclicos | |
MY143677A (en) | Amide prodrug of gemcitabine, compositions and use thereof | |
ATE529430T1 (de) | Caspase-hemmer-propharmaka | |
ECSP066986A (es) | Beta-carbolinas utiles para tratar enfermedades inflamatorias | |
CY1105166T1 (el) | Ενωσεις φωσφονικου οξεος σαν αναστολεις πρωτεασων σepινης | |
NO20055396D0 (no) | Nye fosfonsyreforbindelser som erinproteaseinhibitorer | |
MX2007002525A (es) | Compuestos de difeniletileno y usos de los mismos. | |
ATE461697T1 (de) | Phospholipidderivate von valproinsäure und ihre kombinationen | |
WO2006058720A3 (en) | Novel compounds for the treatment of neurological disorders | |
NI200300045A (es) | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. | |
EA200701852A1 (ru) | Производные аминокислот | |
ATE463468T1 (de) | Verwendung von magnesiumphosphat zur wasserenthärtung | |
PA8616901A1 (es) | Metodos y composiciones para la inhibicion de selectina | |
UY28145A1 (es) | Nuevos compuestos farmaceuticos | |
EA200701815A1 (ru) | 6-гетероарил-1,2,3,4,4а,10в-гексагидрофенантридины в качестве pde-4 ингибиторов для лечения воспалительных заболеваний |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014. |